EMG
SYRS

Ellington Management Group’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Ellington Management Group’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,540
Closed -$227K – 840
2017
Q3 		$227K Buy
+1,540
New +$227K 0.04% 477